Showing results (261-270 of 530) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|September 25, 2020
Medication in adults after atrial switch for transposition of the great arteries: clinical practice and recommendationsOdilia I Woudstra, Joey M Kuijpers, Monique R M Jongbloed, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2020
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarctionMarco Trevisan, Edouard L Fu, Karolina Szummer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 23, 2020
Comparison of P2Y12 receptor inhibitors in patients with ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registriesLeonardo De Luca, Uwe Zeymer, Marc J Claeys, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 28, 2019
An observational study of international normalized ratio control according to NICE criteria in patients with non-valvular atrial fibrillation: the SAIL Warfarin Out of Range Descriptors Study (SWORDS)Daniel E Harris, Daniel Thayer, Ting Wang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 28, 2019
Effectiveness and safety of edoxaban in patients with atrial fibrillation: data from the Danish Nationwide CohortPeter Brønnum Nielsen, Torben Bjerregaard Larsen, Flemming Skjøth, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 27, 2021
Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trialMate Vamos, Jonas Oldgren, Gi-Byoung Nam, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 1, 2021
The association of PRECISE-DAPT score with ischaemic outcomes in patients taking dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysisCole R Clifford, Rene Boudreau, Sarah Visintini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 1, 2017
Recent developments in the science of proarrhythmic cardiac safety of new drugsJ Rick Turner, Dilip R Karnad, Christopher H Cabell, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 20, 2021
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysisPietro Ameri, Vincenzo De Marzo, Giuseppe Biondi Zoccai, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 30, 2025
Effectiveness and safety of rivaroxaban vs. apixaban in patients with atrial fibrillation and peripheral artery diseaseLoubna Dari, Sarah Beradid, Joël Constans, et al.
Pageof 53